DD134642A5 - Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane - Google Patents

Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane

Info

Publication number
DD134642A5
DD134642A5 DD77201314A DD20131477A DD134642A5 DD 134642 A5 DD134642 A5 DD 134642A5 DD 77201314 A DD77201314 A DD 77201314A DD 20131477 A DD20131477 A DD 20131477A DD 134642 A5 DD134642 A5 DD 134642A5
Authority
DD
German Democratic Republic
Prior art keywords
alkylenamineopropanes
aryloxy
hydroxy
preparing new
preparing
Prior art date
Application number
DD77201314A
Other languages
German (de)
English (en)
Inventor
Herbert Koeppe
Anton Mentrup
Ernst-Otto Renth
Kurt Schromm
Wolfgang Hoefke
Gojko Muacevic
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DD134642A5 publication Critical patent/DD134642A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
DD77201314A 1976-10-05 1977-10-03 Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane DD134642A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762644833 DE2644833A1 (de) 1976-10-05 1976-10-05 Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD134642A5 true DD134642A5 (de) 1979-03-14

Family

ID=5989679

Family Applications (5)

Application Number Title Priority Date Filing Date
DD77201314A DD134642A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane
DD77217961A DD148052A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte von arzneimitteln
DD77217954A DD148050A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione
DD77212491A DD143074A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl bzw.benzimidazolinone
DD77217956A DD148051A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen

Family Applications After (4)

Application Number Title Priority Date Filing Date
DD77217961A DD148052A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte von arzneimitteln
DD77217954A DD148050A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione
DD77212491A DD143074A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl bzw.benzimidazolinone
DD77217956A DD148051A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen

Country Status (33)

Country Link
US (7) US4256756A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5368775A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (15) AT361908B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU514600B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE859415A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG33153A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (4) CA1101859A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS197304B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (5) DD134642A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2644833A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK439077A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (16) ES462868A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI69066C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2394534A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (3) GB1592976A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR64229B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK19385A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU177173B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (3) IE46159B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL53043A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU78240A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8500909A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7710840A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO151411C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ185356A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (4) PH15763A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL113879B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT67107B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE442400B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG70884G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU665801A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU40484B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA775905B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
FR2455587A1 (fr) * 1979-05-04 1980-11-28 Continental Pharma Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
US4434174A (en) 1980-02-11 1984-02-28 Berlex Laboratories, Inc. Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
IE810250L (en) 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4473501A (en) * 1981-05-04 1984-09-25 G. D. Searle & Co. Dihydro azino isoquinolines
US4379508A (en) * 1981-10-14 1983-04-12 Nestier Corporation Nesting tray with stacking keyed interlock
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) * 1983-07-09 1985-01-17 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
DE3807922A1 (de) * 1988-03-10 1989-09-21 Boehringer Mannheim Gmbh Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US6557907B2 (en) 1993-05-14 2003-05-06 William W. Rowley Polyethylene connectors
US6860524B1 (en) 1993-05-14 2005-03-01 William W. Rowley Polyolefin connectors
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6848719B2 (en) 2001-09-06 2005-02-01 William W. Rowley Bendable polymer-lined water heater connector
UY28089A1 (es) 2002-11-26 2004-06-30 Smithkline Beecham Corp Compuestos calciliticos
US20070117978A1 (en) * 2002-12-23 2007-05-24 Artesian Therapecutics, Inc Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
WO2006060122A2 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PL2224973T3 (pl) * 2007-11-29 2016-11-30 Środki konserwujące do kosmetyków, środków do pielęgnacji ciała i kompozycji farmaceutycznych
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284529A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1961-10-24
GB1066613A (en) * 1965-03-03 1967-04-26 Ici Ltd Naphthalene derivatives
DE2065365C3 (de) * 1969-11-28 1982-05-06 Teikoku Hormone Mfg. Co. Ltd., Tokyo 1,3-disubstituierte Azetidine sowie Verfahren zu deren Herstellung und ihre Anwendung
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3818017A (en) * 1973-01-04 1974-06-18 Janssen Pharmaceutica Nv 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3894030A (en) * 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) * 1973-07-18 1976-11-24 Ici Ltd Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
ATA56980A (de) 1980-09-15
FI69066B (fi) 1985-08-30
GB1592975A (en) 1981-07-15
ES471804A1 (es) 1979-02-01
AT362365B (de) 1981-05-11
AT363082B (de) 1981-07-10
ES471806A1 (es) 1979-02-01
IE46159B1 (en) 1983-03-09
PL113879B1 (en) 1981-01-31
AT362364B (de) 1981-05-11
AT363081B (de) 1981-07-10
US4255430A (en) 1981-03-10
DE2644833A1 (de) 1978-04-20
AT362362B (de) 1981-05-11
ATA57080A (de) 1980-09-15
CA1127643A (en) 1982-07-13
JPS5368775A (en) 1978-06-19
DD148051A5 (de) 1981-05-06
US4604468A (en) 1986-08-05
IL53043A (en) 1982-01-31
ES471807A1 (es) 1979-02-01
US4343800A (en) 1982-08-10
ES471800A1 (es) 1979-02-01
ES471794A1 (es) 1979-02-01
NZ185356A (en) 1981-05-01
DD148052A5 (de) 1981-05-06
ES471803A1 (es) 1979-02-01
SE7711168L (sv) 1978-05-18
AT361911B (de) 1981-04-10
YU236977A (en) 1983-01-21
PT67107A (de) 1977-11-01
AT364828B (de) 1981-11-25
YU40484B (en) 1986-02-28
FI69066C (fi) 1985-12-10
BE859415A (fr) 1978-04-05
DK439077A (da) 1978-04-06
ES471801A1 (es) 1979-02-01
ES471799A1 (es) 1979-02-01
ATA57280A (de) 1980-10-15
US4256756A (en) 1981-03-17
ATA57880A (de) 1980-10-15
AT363080B (de) 1981-07-10
ATA57180A (de) 1980-09-15
PH15763A (en) 1983-03-22
NO151411B (no) 1984-12-27
AT363079B (de) 1981-07-10
DD148050A5 (de) 1981-05-06
PH16053A (en) 1983-06-09
US4296117A (en) 1981-10-20
PH18363A (en) 1985-06-13
CA1125751A (en) 1982-06-15
US4212877A (en) 1980-07-15
AT361908B (de) 1981-04-10
ATA57680A (de) 1980-12-15
SE442400B (sv) 1985-12-23
AT361913B (de) 1981-04-10
ES471796A1 (es) 1979-02-01
DD143074A5 (de) 1980-07-30
ATA57580A (de) 1980-12-15
GB1592976A (en) 1981-07-15
AU2933377A (en) 1979-04-12
SU665801A3 (ru) 1979-05-30
ES471805A1 (es) 1979-02-01
IL53043A0 (en) 1977-12-30
FR2394534A1 (fr) 1979-01-12
ATA57980A (de) 1980-12-15
ATA679377A (de) 1980-09-15
GR64229B (en) 1980-02-14
LU78240A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-02-02
SG70884G (en) 1985-04-04
ATA57780A (de) 1980-12-15
PT67107B (de) 1980-04-07
IE46158B1 (en) 1983-03-09
HU177173B (en) 1981-08-28
ES471802A1 (es) 1979-02-01
CS197304B2 (en) 1980-04-30
ATA57480A (de) 1980-10-15
BG33153A3 (bg) 1982-12-15
ES471798A1 (es) 1979-02-01
AU514600B2 (en) 1981-02-19
IE46160B1 (en) 1983-03-09
IE822410L (en) 1978-04-05
ATA56880A (de) 1980-09-15
ATA56780A (de) 1980-09-15
US4381309A (en) 1983-04-26
AT361912B (de) 1981-04-10
PH19028A (en) 1985-12-06
GB1592977A (en) 1981-07-15
ES471795A1 (es) 1979-02-01
AT361914B (de) 1981-04-10
AT361915B (de) 1981-04-10
FR2394534B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-04-30
HK19385A (en) 1985-03-22
IE46158L (en) 1978-04-05
IE822409L (en) 1978-04-05
ZA775905B (en) 1979-06-27
NO773384L (no) 1978-04-06
FI772823A7 (fi) 1978-04-06
CA1101859A (en) 1981-05-26
PL201286A1 (pl) 1978-12-04
NO151411C (no) 1985-04-10
AT362363B (de) 1981-05-11
NL7710840A (nl) 1978-04-07
ATA58080A (de) 1981-04-15
ATA57380A (de) 1980-10-15
JPS6210988B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-03-10
ES471808A1 (es) 1979-02-01
ES462868A1 (es) 1978-12-16
CA1126271A (en) 1982-06-22
MY8500909A (en) 1985-12-31
ES471797A1 (es) 1979-02-01

Similar Documents

Publication Publication Date Title
DD134642A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane
AT366361B (de) Verfahren zur herstellung neuer 2-aminotetraline
AT351510B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
DD128133A5 (de) Verfahren zur herstellung neuer piperazinderivate
DD133949A5 (de) Verfahren zur herstellung neuer benzopyranderivate
DD132438A5 (de) Verfahren zur herstellung neuer kortikoide
DD131556A5 (de) Verfahren zur herstellung von 5-m-tolyoxyuracil
DD134351A5 (de) Verfahren zur herstellung neuer pyridobenzodiazepinonen
DD131558A5 (de) Verfahren zur herstellung neuer indolizinderivate
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
DD135390A5 (de) Verfahren zur herstellung neuer aryl-hexafuranoside
AT351046B (de) Verfahren zur herstellung neuer diharnstoffe
DD128270A5 (de) Verfahren zur herstellung neuer azofarbstoffe
AT360971B (de) Verfahren zur herstellung neuer alkinole
LU79077A1 (de) Verfahren zur herstellung neuer benzothiopyranderivate
DD130416A4 (de) Verfahren zur herstellung von o-nitrobenzylbromid
DD133799A1 (de) Verfahren zur herstellung neuer n-heterocyclisch substituierter adamantancarbonsaeureamide
DD131169A5 (de) Verfahren zur herstellung neuer azatetracyclen
AT350528B (de) Verfahren zur herstellung neuer fluoracylresorcine
DD130152A1 (de) Verfahren zur herstellung von polyaethylen
AT348162B (de) Verfahren zur herstellung neuer d-homosteroide
AT355239B (de) Verfahren zur herstellung neuer d-homosteroide
ATA590279A (de) Verfahren zur herstellung neuer 2-aminotetraline
ATA111177A (de) Verfahren zur herstellung neuer thiazolinylbenzimidazolderivate
AT341531B (de) Verfahren zur herstellung neuer octahydropyridoindolobenzazepine